Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T01:58:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.4%
    Check dated 2025-01-12T22:35:19.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-01-05T15:24:52.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-12-29T09:22:38.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-12-22T07:20:53.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.8%
    Check dated 2024-12-14T23:16:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.